What Is a SAFE (Simple Agreement for Future Equity)? How SAFE Financing Works

Search Fintrev

Search our guides, reviews and glossary.

A simple agreement for future equity (SAFE) is a contract in which an investor gives a startup cash now in exchange for the right to receive shares later, when a specified event occurs. That event is usually the company’s next priced equity round, a sale of the company or an IPO. Until then, the investor owns no stock. The SAFE sets the terms on which the money will convert, typically a valuation cap, a discount or both, so the company and investor can complete the deal without agreeing on what the startup is worth today.

SAFE financing is a seed-stage tool. Y Combinator introduced the instrument in 2013 as a shorter, faster alternative to convertible notes. In 2018 it released a post-money version, which changed how ownership is calculated. The name says “simple,” not “safe.” A SAFE is one of the riskiest positions an investor can hold in a company, because it ranks behind creditors and may never become equity at all.

How a SAFE Works

A startup and an investor sign a standardized agreement. The investor wires a “purchase amount,” and the company records an obligation to issue shares in the future. No price per share is set. Instead, the agreement defines how that price will be calculated when conversion happens.

Triggering events

A SAFE spells out what happens in each of three situations:

1. Equity financing. The company sells preferred stock to new investors at a set price per share. The SAFE converts into shares, usually a series of preferred stock with the same rights as the new round, at the SAFE’s conversion price.
2. Liquidity event. The company is acquired or goes public before any priced round. The widely used standard form gives the investor the greater of their purchase amount back in cash or the value of the shares they would have received at the cap.
3. Dissolution. The company winds down. SAFE holders are entitled to a return of their purchase amount, paid only after the company’s debts and only if money is left.

If none of these happens, the SAFE stays outstanding indefinitely. A company that becomes profitable, never raises another priced round and is never sold can leave its SAFE investors holding a contract that never turns into shares.

Valuation cap and discount

The valuation cap sets the highest company valuation at which the SAFE will convert. If the priced round values the company above the cap, the SAFE converts as though the valuation were the cap, so the investor receives more shares per dollar than the new investors do.

The discount gives the SAFE investor a percentage off the price per share paid in the priced round. A 20% discount means the SAFE converts at 80% of the new round price.

Standard SAFEs come in several versions: cap only, discount only, cap and discount, and an uncapped version with a “most favored nation” (MFN) clause. Under an MFN SAFE, if the company later issues SAFEs on better terms, the holder can adopt those terms. When an agreement has both a cap and a discount, the investor gets whichever produces the lower price per share.

Converting a SAFE: Formula and Worked Example

At a priced round, the conversion price for a SAFE with both a cap and a discount is:

Conversion price = lower of (cap price, discount price)

where

• Cap price = valuation cap ÷ company capitalization (the share count defined in the SAFE)
• Discount price = new round price per share × (1 − discount rate)

Shares issued to the SAFE holder = purchase amount ÷ conversion price

Hypothetical example. An angel invests $100,000 through a post-money SAFE with a $5 million valuation cap and a 20% discount. Two years later, the company raises a Series A at $2.00 per share. Assume the company capitalization used in the SAFE calculation is 10,000,000 shares.

• Cap price: $5,000,000 ÷ 10,000,000 = $0.50 per share
• Discount price: $2.00 × 0.80 = $1.60 per share
• Conversion price: the lower figure, $0.50
• Shares issued: $100,000 ÷ $0.50 = 200,000 shares

The Series A investors pay $2.00 per share, so the same $100,000 would buy them 50,000 shares. The cap gives the SAFE holder four times as many shares. Here the discount does not matter, because the round price is well above the cap price. If the Series A had been priced at $0.55 per share, the discount price would have been $0.44, below the $0.50 cap price, and the discount would have set the conversion price instead.

Because the example uses a post-money SAFE, the investor could have predicted their stake on signing day: $100,000 ÷ $5,000,000 = 2% of the company’s capitalization just before the Series A. The 200,000 shares are 2% of the 10,000,000-share capitalization.

Pre-Money vs. Post-Money SAFEs

The difference between the two versions comes down to one input: whether the SAFE money itself counts toward the capitalization that the cap is divided by.

Pre-money SAFE. The original 2013 design calculates the cap price on the company’s capitalization before the SAFEs convert. Each SAFE’s share count is fixed by the cap, so every additional SAFE the company sells adds more shares at conversion. Those shares dilute founders and earlier SAFE holders alike. An investor cannot know their percentage until the company stops raising SAFE money and the priced round sets the final numbers.

Post-money SAFE. The cap is treated as a valuation that already includes all the SAFE money raised. The investor’s ownership equals the purchase amount divided by the post-money cap, measured just before the priced round. If the company raises more SAFEs afterward, those additional SAFEs dilute the existing shareholders, mainly the founders, rather than the earlier SAFE holders. Everyone, SAFE holders included, is still diluted by the new money in the priced round itself.

Hypothetical comparison. A startup raises $1 million on SAFEs with a $10 million cap. On a post-money SAFE, those investors know they will own 10% before the Series A. On a pre-money SAFE with the same headline numbers, the $10 million excludes the SAFE money, so the investors end up with roughly $1 million ÷ $11 million, a little over 9%, and less if the company keeps issuing SAFEs before it prices a round.

For founders, the post-money version makes the cost of each SAFE transparent but puts the dilution from stacking several SAFEs on them, which can produce a much larger combined investor stake than any single agreement suggests.

Why Startups and Investors Use SAFEs

Benefits for startups

• No valuation negotiation now. Very early companies have little revenue, few comparables and cash flows too uncertain for standard methods like a discounted cash flow model. A SAFE defers the price-per-share question to a later round. A cap is still an implicit valuation ceiling, so founders do negotiate a number. They just avoid fixing a price per share and issuing stock.
• Speed and lower cost. Standard SAFE documents are short and widely recognized, so legal review and negotiation take less time than for a priced round with a full set of preferred stock terms.
• Rolling closes. A company can sign SAFEs with different investors on different dates, sometimes with different caps, instead of coordinating one closing.
• No debt pressure. No interest accrues and there is no maturity date, so a company burning cash before revenue faces no repayment deadline.
• Control. SAFE holders generally have no voting rights before conversion, so founders keep board and voting control during the earliest stage.

Benefits for investors

• Early-stage pricing. The cap and discount mean the investor pays less per share than later investors if the company grows into a higher valuation.
• Smaller tickets. Seed checks are typically small, which lets an investor spread money across more companies.
• Possible extra rights. Some deals add a side letter granting pro rata rights, which let the investor buy into the next round to maintain their percentage.

Risks and Limitations of a SAFE

For investors:

• No ownership until conversion. A SAFE holder has no shares, no voting rights and no dividends. If no triggering event occurs, there is no maturity date to force repayment.
• Weak position in a failure. In a dissolution, SAFE holders are paid after creditors and have no claim to interest or security.
• Little information. SAFE holders typically have no contractual right to financial statements unless the agreement or a side letter grants it.
• Total loss. Most of the risk sits in the scenario the SAFE handles worst: a startup that runs out of money before raising a priced round.

For founders:

• Hidden dilution. Because SAFEs do not appear as shares until conversion, founders can underestimate how much of the company they have already sold.
• Cap overhang. A high cap set during an optimistic seed raise can create pressure if the company later grows slowly. If the next round is priced below expectations, the caps and discounts deliver more shares to SAFE holders, and founders absorb the extra dilution.
• Negotiation in the priced round. New lead investors often factor the converting SAFEs into their price and option pool demands, which can shift more dilution onto the founders.

SAFE vs. Convertible Note, Priced Equity and Loans

The key distinction is from priced equity. A priced round issues stock immediately at an agreed price per share, usually with a full set of investor protections. A SAFE issues no stock and converts by formula. Compared with a convertible note, a SAFE removes the interest and maturity date, the two features that make a note a debt with a deadline.

Legal, Regulatory and Tax Points

Securities law

A SAFE is a security under U.S. law, so issuing one requires registration or an exemption under federal and state securities rules. Most private startups rely on a Regulation D exemption and file a Form D with the SEC within 15 days of the first sale. Some states also require their own “blue-sky” notice filings. SAFEs are also offered to retail investors through Regulation Crowdfunding platforms. The SEC has published an investor bulletin warning crowdfunding investors that a SAFE is not equity and may never convert.

Key contract terms

Investors generally get no voting rights before conversion, although an agreement can grant votes on matters that directly affect the SAFE, such as amendments. Some SAFEs let the company repurchase the investor’s rights instead of converting them.

Tax treatment

Buying a SAFE is generally not a taxable event for the investor, and the company generally treats the cash as invested capital rather than revenue. After conversion, gains on the shares are subject to capital gains tax when the investor sells. Beyond that, the treatment is not fully settled. A SAFE can be characterized as equity or as a forward contract, and the answer can affect when the holding period starts, which in turn affects long-term capital gains treatment and eligibility for certain small business stock benefits. Investors and companies with meaningful amounts at stake get tax advice on the specific agreement.

How a SAFE Affects the Cap Table

A SAFE adds no shares to the capitalization table when it is signed, so many companies track outstanding SAFEs separately, alongside options and other convertibles. At conversion, the SAFE holders’ shares are issued and the ownership percentages of founders, option holders and earlier shareholders fall. Running the formula above for every outstanding SAFE before the priced round shows founders and new investors the real post-round ownership.

Can SAFEs Be Used in Later Rounds?

SAFEs are built for seed and pre-seed financing, where valuation is hardest to pin down. Companies sometimes use them between priced rounds as a bridge, for example after a Series A and before a Series B, with a cap and discount adjusted to the company’s more advanced stage. Larger institutional rounds usually move to priced preferred stock, because investors at that stage expect board seats, protective provisions and a fixed price per share.

FAQs

The Bottom Line

SAFEs matter most to seed-stage founders and angel investors who want to close a deal quickly without fixing a price per share. Investors should treat a SAFE as a high-risk claim that ranks behind creditors and may never convert. Founders should run the conversion formula for every outstanding SAFE before a priced round so they see how much of the company they have already sold.